RUBATTO, MARCO
RUBATTO, MARCO
SCIENZE MEDICHE
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era
2021-01-01 Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
2022-01-01 Rubatto, Marco; Merli, Martina; Avallone, Gianluca; Agostini, Andrea; Mastorino, Luca; Caliendo, Virginia; Barcellini, Amelia; Vitolo, Viviana; Valvo, Francesca; Fierro, Maria Teresa; Ribero, Simone; Quaglino, Pietro
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit
2021-01-01 Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Merli M.; Tonella L.; Ribero S.; Fierro M.T.
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study
2022-01-01 Avallone G.; Roccuzzo G.; Torres-Navarro I.; Gelato F.; Mastorino L.; Agostini A.; Merli M.; Cavallo F.; Rubatto M.; Senetta R.; Botella Estrada R.; Ribero S.; Quaglino P.
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden?
2021-01-01 Mastorino L.; Dapavo P.; Avallone G.; Merli M.; Cariti C.; Rubatto M.; Pala V.; Quaglino P.; Ribero S.
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma
2021-01-01 Avallone, Gianluca; Trunfio, Mattia; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; Caracciolo, Daniele; Calcagno, Andrea; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro; Ribero, Simone
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer
2022-01-01 Rubatto, Marco; Sciamarrelli, Nadia; Borriello, Silvia; Pala, Valentina; Mastorino, Luca; Tonella, Luca; Ribero, Simone; Quaglino, Pietro
Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study
2022-01-01 Amabile, Simone; Tonella, Luca; Rubatto, Marco; Argenziano, Giuseppe; Babino, Graziella; Frascione, Pasquale; Dika, Emi; Giacomelli, Luca; Parodi, Aurora; Quaglino, Pietro
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials
2021-01-01 Amabile S.; Roccuzzo G.; Pala V.; Tonella L.; Rubatto M.; Merli M.; Fava P.; Ribero S.; Fierro M.T.; Queirolo P.; Quaglino P.
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study
2022-01-01 Gullo G.; Rubatto M.; Fava P.; Brizio M.; Tonella L.; Ribero S.; Medri M.; Avallone G.; Mastorino L.; Fierro M.T.; Stanganelli I.; Quaglino P.
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19
2020-01-01 Pala L.; Conforti F.; Saponara M.; De Pas T.; Giugliano F.; Omodeo Sale E.; Jemos C.; Rubatto M.; Agostini A.; Quaglino P.; Fava P.; Fierro M.T.; Queirolo P.
Dramatic response of face desmoplastic melanoma after two doses of immunotherapy
2023-01-01 Rubatto, Marco; Gelato, Federica; Broganelli, Paolo; Fava, Paolo; Senetta, Rebecca; Avallone, Gianluca; Mastorino, Luca; Grandinetti, Damiano; Ribero, Simone; Quaglino, Pietro
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome?
2022-01-01 Cavallo, Francesco; Roccuzzo, Gabriele; Avallone, Gianluca; Conforti, Claudio; Zalaudek, Iris; Giordano, Silvia; Rubatto, Marco; Fava, Paolo; Ribero, Simone; Quaglino, Pietro
Immunotherapy in transplanted patients: A special population that can no longer be ignored
2021-01-01 Rubatto M.; Merli M.; Agostini A.; Avallone G.; Mastorino L.; Fava P.; Biancone L.; Rossetti M.; Fierro M.T.; Ribero S.; Quaglino P.
Immunotherapy in Xeroderma Pigmentosum: A case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review
2021-01-01 Rubatto M.; Merli M.; Avallone G.; Agostini A.; Mastorino L.; Caliendo V.; Barcellini A.; Vitolo V.; Valvo F.; Fierro M.T.; Ribero S.; Quaglino P.
Liver metastases and immunotherapy: A barrier to response for metastatic melanoma
2023-01-01 Marco Rubatto; Nicole Macagno; Ginevra Pastorin; Paolo Fava; Luca Ceroni; Simone Ribero; Pietro Quaglino
Melanoma management during the covid-19 pandemic emergency: A literature review and single-center experience
2021-01-01 Cariti C.; Merli M.; Avallone G.; Rubatto M.; Marra E.; Fava P.; Caliendo V.; Picciotto F.; Gualdi G.; Stanganelli I.; Fierro M.T.; Ribero S.; Quaglino P.
Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit
2020-01-01 Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Agostini A.; Tonella L.; Ribero S.; Fierro M.T.
Misuse, consequences and phototoxic skin-related effects of Rutaceae: a comprehensive literature review
2021-01-01 Avallone, Gianluca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Siliquini, Niccolò; Rubatto, Marco; Fierro, Maria Teresa; Ribero, Simone; Quaglino, Pietro
Nonmelanoma skin cancer arising on tattoos
2022-01-01 Rubatto, Marco; Gelato, Federica; Mastorino, Luca; Giordano, Silvia; Ribero, Simone; Quaglino, Pietro
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Acute appendicitis secondary to desmoplastic melanoma metastasis in immune-checkpoint inhibitors era | 2021 | Avallone, Gianluca; Astrua, Chiara; Fava, Paolo; Tonella, Luca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; De Pasquale, Rocco; Conti, Luca; Quaglino, Pietro; Ribero, Simone | |
Addendum: Immunotherapy in Xeroderma Pigmentosum: a case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review | 2022 | Rubatto, Marco; Merli, Martina; Avallone, Gianluca; Agostini, Andrea; Mastorino, Luca; Caliendo, Virginia; Barcellini, Amelia; Vitolo, Viviana; Valvo, Francesca; Fierro, Maria Teresa; Ribero, Simone; Quaglino, Pietro | |
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: Experience from an Italian skin cancer unit | 2021 | Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Merli M.; Tonella L.; Ribero S.; Fierro M.T. | |
Association between Primary Cutaneous B-cell Lymphomas and Other Skin Cancers: A Multicentre Cohort Study | 2022 | Avallone G.; Roccuzzo G.; Torres-Navarro I.; Gelato F.; Mastorino L.; Agostini A.; Merli M.; Cavallo F.; Rubatto M.; Senetta R.; Botella Estrada R.; Ribero S.; Quaglino P. | |
Biologic treatment for psoriasis in cancer patients: should they still be considered forbidden? | 2021 | Mastorino L.; Dapavo P.; Avallone G.; Merli M.; Cariti C.; Rubatto M.; Pala V.; Quaglino P.; Ribero S. | |
Case Report: Atypical Cutaneous Presentation of Human T-cell Lymphotropic Virus Type 1-Related Adult T-cell Lymphoma | 2021 | Avallone, Gianluca; Trunfio, Mattia; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Rubatto, Marco; Caracciolo, Daniele; Calcagno, Andrea; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro; Ribero, Simone | |
Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer | 2022 | Rubatto, Marco; Sciamarrelli, Nadia; Borriello, Silvia; Pala, Valentina; Mastorino, Luca; Tonella, Luca; Ribero, Simone; Quaglino, Pietro | |
Clinical evaluation of hydration index using a corneometer in metastatic melanoma patients treated with BRAF/MEK inhibitors: a prospective study | 2022 | Amabile, Simone; Tonella, Luca; Rubatto, Marco; Argenziano, Giuseppe; Babino, Graziella; Frascione, Pasquale; Dika, Emi; Giacomelli, Luca; Parodi, Aurora; Quaglino, Pietro | |
Clinical significance of distant metastasis-free survival (Dmfs) in melanoma: A narrative review from adjuvant clinical trials | 2021 | Amabile S.; Roccuzzo G.; Pala V.; Tonella L.; Rubatto M.; Merli M.; Fava P.; Ribero S.; Fierro M.T.; Queirolo P.; Quaglino P. | |
Cutaneous side effects and types of dermatological reactions in metastatic melanoma patients treated by immunotherapies or targeted therapies: A retrospective single center study | 2022 | Gullo G.; Rubatto M.; Fava P.; Brizio M.; Tonella L.; Ribero S.; Medri M.; Avallone G.; Mastorino L.; Fierro M.T.; Stanganelli I.; Quaglino P. | |
Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19 | 2020 | Pala L.; Conforti F.; Saponara M.; De Pas T.; Giugliano F.; Omodeo Sale E.; Jemos C.; Rubatto M.; Agostini A.; Quaglino P.; Fava P.; Fierro M.T.; Queirolo P. | |
Dramatic response of face desmoplastic melanoma after two doses of immunotherapy | 2023 | Rubatto, Marco; Gelato, Federica; Broganelli, Paolo; Fava, Paolo; Senetta, Rebecca; Avallone, Gianluca; Mastorino, Luca; Grandinetti, Damiano; Ribero, Simone; Quaglino, Pietro | |
Extensive "halo naevi" phenomenon and regression of melanin during nivolumab treatment in metastatic melanoma: A predictor of a better outcome? | 2022 | Cavallo, Francesco; Roccuzzo, Gabriele; Avallone, Gianluca; Conforti, Claudio; Zalaudek, Iris; Giordano, Silvia; Rubatto, Marco; Fava, Paolo; Ribero, Simone; Quaglino, Pietro | |
Immunotherapy in transplanted patients: A special population that can no longer be ignored | 2021 | Rubatto M.; Merli M.; Agostini A.; Avallone G.; Mastorino L.; Fava P.; Biancone L.; Rossetti M.; Fierro M.T.; Ribero S.; Quaglino P. | |
Immunotherapy in Xeroderma Pigmentosum: A case of advanced cutaneous squamous cell carcinoma treated with cemiplimab and a literature review | 2021 | Rubatto M.; Merli M.; Avallone G.; Agostini A.; Mastorino L.; Caliendo V.; Barcellini A.; Vitolo V.; Valvo F.; Fierro M.T.; Ribero S.; Quaglino P. | |
Liver metastases and immunotherapy: A barrier to response for metastatic melanoma | 2023 | Marco Rubatto; Nicole Macagno; Ginevra Pastorin; Paolo Fava; Luca Ceroni; Simone Ribero; Pietro Quaglino | |
Melanoma management during the covid-19 pandemic emergency: A literature review and single-center experience | 2021 | Cariti C.; Merli M.; Avallone G.; Rubatto M.; Marra E.; Fava P.; Caliendo V.; Picciotto F.; Gualdi G.; Stanganelli I.; Fierro M.T.; Ribero S.; Quaglino P. | |
Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit | 2020 | Quaglino P.; Fava P.; Brizio M.; Marra E.; Rubatto M.; Agostini A.; Tonella L.; Ribero S.; Fierro M.T. | |
Misuse, consequences and phototoxic skin-related effects of Rutaceae: a comprehensive literature review | 2021 | Avallone, Gianluca; Mastorino, Luca; Agostini, Andrea; Merli, Martina; Siliquini, Niccolò; Rubatto, Marco; Fierro, Maria Teresa; Ribero, Simone; Quaglino, Pietro | |
Nonmelanoma skin cancer arising on tattoos | 2022 | Rubatto, Marco; Gelato, Federica; Mastorino, Luca; Giordano, Silvia; Ribero, Simone; Quaglino, Pietro |